News

After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.

Your patient tells you to get some rest, but they don’t know why you’re tired. What do you tell them?

A rare robust finding from a study on bipolar depression.

The world is facing a cognition crisis. Here’s how to face it with measurement-based cognitive care.

The wave of anti-Asian sentiment has exposed flaws in the health care system. What can psychiatry do to help?

If approved, SLS-002 would be only the second approved product for ASIB.

New research may help better understand psychosis etiology as well as provide potential biomarkers for psychosis.

"I can still hear my patient shriek..."

The COVID-19 pandemic should have us reflecting on the state of our health care system as well as embarking in a national dialogue on what type of system we want for this country and what investments we need to attain that vision.

Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.

Anything new to discuss...?

Apathy occurs throughout the spectrum of neurocognitive disorders, but it is easy to mistake for other conditions, like depression. How can clinicians identify apathy, and treat it?

Cannabis has been heralded as a treatment for many conditions, but what about its psychiatric risks?

How should the sociopolitical nature of PTSD as a diagnosis inform our understanding of trauma?

Can you spare a minute to share your insights?

Many mental health professionals have also used mental health services. What role should their personal experience play in their clinical practice—if any?

Are you interested in sharing your story?

This CME covers how CNS-related psychosis may require medical interventions beyond antipsychotic and other psychotropic medications.

Look for the light, magnify it, and reflect it back.

To combat drug overdoses, the Rhode Island governor signed a bill allowing people to consume pre-obtained drugs under safe, professional supervision of trained staff.

Got anything smart to say?

Recognizing the need to stay up-to-date with psychopharmacology and issues affecting psychiatric practice, Psychiatric Times' Editor in Chief invites readers to join him and leaders in psychiatry for a fascinating educational conference.

Should psychiatrists help patients end their own lives, even if it is technically legal?

As the country opens up this summer, it's time to enjoy friends and family—and to build resilience for the challenges that still lie ahead.

Following criticism for its wide-labeled June approval, the FDA has decided to narrow the patient recommendation for aducanumab.

1 in 3 COVID-19 survivors experience persistent consequences. What can psychiatry do to help?

Frankness, honesty, and humor make this doctor’s poetry collection special.

Three women describe the massive impact COVID-19 has had on their lives.

As much as it is important to honor our country, it is also important to honor its ideals and continue the pursuit for such—for everyone.

Yes, we need better crisis management, but what we really need is better crisis prevention.